Carlyle picks up 14% of Meinian Onehealth

Investing via its RMB fund Beijing Carlyle Investment Centre, through this transaction Carlyle will attempt to leverage the healthcare industry expertise it has gained by working with portfolio companies such as China's Concord Medical Service and Australia-based Healthscope.

Founded in 2004, Meinian Onehealth offers general medical examinations, disease screening and services such as doctor referrals and traditional Chinese medical services to individual and corporate customers. It became China's largest private provider of preventive healthcare check-up services in 2011, thanks to its 83 clinics in 41 cities, around 20 of which will be opened by the end of 2012.

"As the Chinese population matures and becomes increasingly aware of the importance of preventive care, there is a strong domestic demand for quality preventive healthcare check-up services," commented Janine Feng, managing director of Carlyle. "Meinian Onehealth is a prominent market player with an extensive national clinic network and an experienced management team."

Meinian Chairman Yu Rong added that the partnership with Carlyle should allow the company to develop its business by expanding its network of clinics and providing service differentiation, as well as exploring more "value-added initiatives".

Carlyle - and fellow buyout giant TPG - acquired Healthscope, Australia's second-largest hospital operator, for A$2.7 billion ($2.5 billion) in 2010. It was the biggest buyout in the nation since 2007.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Save this article  
• Send to  

• Topics
• Healthcare
• Greater China
• Expansion
• Growth capital
• China
• The Carlyle Group
• healthcare